Zivo Bioscience Cash Flow From Operations vs. Total Asset

ZIVOWDelisted Stock  USD 0.55  0.07  14.58%   
Based on the measurements of profitability obtained from Zivo Bioscience's financial statements, Zivo Bioscience Warrants may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Zivo Bioscience's ability to earn profits and add value for shareholders.
For Zivo Bioscience profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Zivo Bioscience to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Zivo Bioscience Warrants utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Zivo Bioscience's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Zivo Bioscience Warrants over time as well as its relative position and ranking within its peers.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Please note, there is a significant difference between Zivo Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zivo Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zivo Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Zivo Bioscience Warrants Total Asset vs. Cash Flow From Operations Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Zivo Bioscience's current stock value. Our valuation model uses many indicators to compare Zivo Bioscience value to that of its competitors to determine the firm's financial worth.
Zivo Bioscience Warrants is rated second in cash flow from operations category among its peers. It is rated fourth in total asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Zivo Bioscience by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Zivo Total Asset vs. Cash Flow From Operations

Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.

Zivo Bioscience

Operating Cash Flow

 = 

EBITDA

-

Taxes

 = 
(7.1 M)
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Zivo Bioscience

Total Asset

 = 

Tangible Assets

+

Intangible Assets

 = 
2.12 M
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.

Zivo Total Asset Comparison

Zivo Bioscience is currently under evaluation in total asset category among its peers.

Zivo Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Zivo Bioscience. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Zivo Bioscience position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Zivo Bioscience's important profitability drivers and their relationship over time.

Use Zivo Bioscience in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Zivo Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zivo Bioscience will appreciate offsetting losses from the drop in the long position's value.

Zivo Bioscience Pair Trading

Zivo Bioscience Warrants Pair Trading Analysis

The ability to find closely correlated positions to Zivo Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Zivo Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Zivo Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Zivo Bioscience Warrants to buy it.
The correlation of Zivo Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Zivo Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Zivo Bioscience Warrants moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Zivo Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Zivo Bioscience position

In addition to having Zivo Bioscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Management Thematic Idea Now

Management
Management Theme
Companies providing management services to businesses. The Management theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Management Theme or any other thematic opportunities.
View All  Next Launch
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Consideration for investing in Zivo Stock

If you are still planning to invest in Zivo Bioscience Warrants check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zivo Bioscience's history and understand the potential risks before investing.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Money Managers
Screen money managers from public funds and ETFs managed around the world
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Global Correlations
Find global opportunities by holding instruments from different markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.